Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions
Sponsor: R3 Stem Cell
Summary
The aim of the study is to determine the efficacy of an Amniotic Fluid Tissue Product for pain relief and functional improvements for all types of musculoskeletal conditions. The study is prospective, with outcome measures being obtained at numerous time points after the regenerative procedure.
Official title: Evaluation of Regenerative Medicine Outcomes With Umbilical Allograft for Musculoskeletal Conditions
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2022-01-01
Completion Date
2030-01-01
Last Updated
2021-09-17
Healthy Volunteers
Yes
Conditions
Interventions
Umbilical Allograft
The umbilical allograft is regulated by the FDA and comes from a lab that is FDA registered.
Locations (1)
Advanced Stem Cell Institute
Encino, California, United States